Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
72
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)

Mitsukuni Suenaga1 Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, JapanCorrespondence[email protected]
,
Yoshiya Fujimoto2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Satoshi Matsusaka1 Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Eiji Shinozaki1 Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Takashi Akiyoshi2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Satoshi Nagayama2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Yosuke Fukunaga2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Masatoshi Oya2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Masashi Ueno2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
,
Nobuyuki Mizunuma1 Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
&
Toshiharu Yamaguchi2 Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
 show all
Pages 1111-1118 | Published online: 18 May 2015

References

  • NationalCancerCenterCenterfor Cancer Control and Information ServicesCancer Statistics in Japan2012 Available from: http://ganjoho.jp/public/statistics/backnumber/2012_en.htmlAccessed April 19, 2015
  • YoshinoTMizunumaNYamazakiKTAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled Phase 2 trialLancet Oncol201213993100122951287
  • HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancerN Engl J Med20043502335234215175435
  • KabbinavarFHurwitzHIFehrenbacherLPhase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancerJ Clin Oncol200321606512506171
  • KabbinavarFFSchulzJMcCleodMAddition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized Phase II trialJ Clin Oncol2005233697370515738537
  • SaltzLBClarkeSDíaz-RubioEBevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized Phase III studyJ Clin Oncol2007262013201918421054
  • GiantonioBJCatalanoPJMeropolNJBevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200J Clin Oncol2006251539154417442997
  • RobinsonSManasDMPedleyISystemic chemotherapy and its implications for resection of colorectal liver metastasisSurg Oncol201120577219962301
  • NordlingerBVan CutsemEGruenbergerTCombination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelAnn Oncol20092098599219153115
  • Japanese Society for Cancer of the Colon and RectumGeneral rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classificationSurg Today198313557573
  • AndréTBoniCMounedji-BoudiafLOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med20043502343235115175436
  • KueblerJPWieandHSO’ConnellMJOxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07J Clin Oncol2007252198220417470851
  • de GramontAVan CutsemESchmollHJBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a Phase 3 randomised controlled trialLancet Oncol2012131225123323168362
  • FoxTROT Collaborative GroupFeasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trialLancet Oncol2012131152116023017669
  • NordlingerBSorbyeHGlimeliusBPerioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialLancet20083711007101618358928
  • PrimroseJFalkSFinch-JonesMSystemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trialLancet Oncol20141560161124717919
  • GruenbergerBTamandlDSchuellerJBevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancerJ Clin Oncol2008261830183518398148
  • WongRCunninghamDBarbachanoYA multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resectionAnn Oncol2011222042204821285134

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.